Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Thromboembolic And Anticoagulation Scores
Interactive worksheet4 clinical inputsPatient data not stored

HERDOO2 Score Calculator

HERDOO2 Score: Explanation and Clinical Context The HERDOO2 score is a clinical decision tool designed to identify women with unprovoked venous thromboembolism (VTE) who may safely discontinue anticoagulation after 5–12 months of therapy. It includes four variables: Hyperpigmentation, Edema, or Redness in either leg; D-dimer >250 μg/L; Obesity (BMI >30 kg/m²); and Older age >65 years. Each variable scores 1 point if

Interactive worksheet

Clinical inputs

0/4 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

HERDOO2 Score: Explanation and Clinical Context The HERDOO2 score is a clinical decision tool designed to identify women with unprovoked venous thromboembolism (VTE) who may safely discontinue anticoagulation after 5–12 months of therapy. It includes four variables: Hyperpigmentation, Edema, or Redness in either leg; D-dimer >250 μg/L; Obesity (BMI >30 kg/m²); and Older age >65 years. Each variable scores 1 point if present.

Patients with a score of 0–1 are considered low risk for recurrent VTE and may safely stop anticoagulation. Those with a score >2 are at higher risk and should generally continue anticoagulation. This tool allows clinicians to balance the benefits of ongoing anticoagulation against bleeding risk and patient preferences.

Evidence & references1 primary source mapped
  1. Source 1

    Rodger MA, et al. HERDOO2 Rule: Identification of Women with Unprovoked Venous Thromboembolism at Low Risk for Recurrence Who Can Stop Anticoagulants. BMJ. 2009;338:b688. doi:10.1136/bmj.b688

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

sPESI (Simplified Pulmonary Embolism Severity Index) Calculator

Thromboembolic And Anticoagulation Scores
Score mapped

PERC Rule (Pulmonary Embolism Rule-out Criteria) Calculator

Thromboembolic And Anticoagulation Scores
Reference

4Ts Score for Heparin Induced Thrombocytopenia Calculator

Thromboembolic And Anticoagulation Scores
Interactive worksheet

Wells Pulmonary Embolism (PE) Score Calculator

Thromboembolic And Anticoagulation Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.